Avalon GloboCare Corp. Common Stock
ALBTAvalon GloboCare Corp. is a biotechnology company focused on developing and commercializing cell-based therapies and diagnostic products. The company explores innovative solutions in regenerative medicine, immunotherapy, and personalized healthcare, aiming to advance treatment options in various medical fields.
$1.38 +0.14 (10.14%)
Company News
Avalon GloboCare Reports Q3 2025 Progress with KetoAirâ„¢, Holistic Health Initiatives, and International Expansion
Avalon GloboCare expanded its KetoAirâ„¢ breathalyzer device internationally to the UK, launched a first responder wellness program in Nevada, and showcased its metabolic health monitoring technology at a London summit.
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - ALBT, NDOI, DNB, RSLS
The M&A Class Action Firm is investigating the proposed mergers of Avalon GloboCare, Endo, Dun & Bradstreet, and ReShape Lifesciences, providing details on the terms of each deal.
